Droia Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureEcoR1 CapitalGV (Google Ventures)The Column GroupJJDCJohnson & Johnson Innovation – JJDC+1 more
Vico Therapeutics is a genetic medicine company developing antisense oligonucleotide (ASO) therapies that target the CAG repeat expansion mutation underlying polyglutamine diseases such as Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechHealthtech
Co-investorsKurma PartnersPureos BioventuresSeroba Life SciencesEQT Life SciencesEurazeoIdinvest Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.